A new hemoglobin variant, hemoglobin (Hb) Nunobiki, was detected in a Japanese male with marginal erythrocytosis. The Hb Nunobiki component amounted to 13.1% of the total hemoglobin. Structural analysis of this variant established the substitution of a cysteine for an arginine at the carboxy terminus of the a-chain (a]141).
Introduction
Human adult hemoglobin (Hb A)' is a tetrameric protein consisting of two pairs of a and f3 polypeptide chains. Amino acid sequence anomalies, which primarily occur as a result of gene mutation in the a-and a-chains, may alter the physicochemical characteristics of hemoglobin, such as its solubility, stability, electrophoresis, oxygen affinity, resistance to acid or alkali denaturation, auto-qxidation, and its absorption spectrum (1).
Some of these alterations cause severe pathologic conditions such as sickle cell anemia, methemoglobinemia, hemolytic anemia, and polycythemia (2) .
Researchers have previously tried to explain such alterations in physico-chemical characteristics based on the detailed structure of the hemoglobin (Hb) molecule. Changes in oxygen Hb A, adult hemoglobin; Hb F, fetal hemoglobin; Kb, kilobase pairs; Nb, Nunobiki; PCMB, p-chloromercurybenzoic acid; PMB, p-mercurybenzoic acid. affinity have thus been accounted for by an amino acid substitution at the heme linkage, the heme pocket, the a,#, dimeric contact, the al,,B tetrameric contact, and a carboxy terminal end of the a or the 03 subunit (3) .
The newly discovered abnormal hemoglobin described in this paper is the first hemoglobin variant with a cysteine at a carboxy terminus of an a chain. High oxygen affinity and slow auto-oxidation of this variant may be explained by this substitution.
Analysis of the globin gene responsible for hemoglobin production in the propositus is also described in an attempt to explain the reason for the low proportion of this abnormal hemoglobin.
Methods
A specimen of venous blood was withdrawn from the patient into a heparinized bottle. Hematologic data were obtained by the standard method of laboratory examination (4) . The hemolysate was prepared by the conventional method and identification of the abnormal hemoglobin was accomplished by isoelectric focusing with a polyacrylamide gel slab containing Ampholine, pH 5-9 (LKB Instruments, Inc., Gaithersburg, MD). The abnormal hemoglobin Nunobiki (Hb Nb) was then purified from the whole hemolysate by DEAE-cellulose (DE-52, Whatman Laboratory Products, Inc., Clifton, NJ) column chromatography (5) . Hemoglobin instability and heat denaturation tests were carried out by a method described elsewhere (6, 7) .
The absorption spectra in several hemoglobin forms of purified Hb Nb were measured at a wavelength range of from 250 to 650 nm with a spectrophotometer (Carry type 118C, Varian Associates, Inc., Palo Alto, CA). Auto-oxidizability was examined at 370C in 0.05 M bis (2- hydroxyethyl)iminotris(hydroxymethyl)methane, 0.1 M NaCl buffer, pH 7.4, by measuring the increase in absorbance at 630 nm together with its absorption spectrum in the visible wave length. The oxygen equilibrium curves of the hemoglobin solution were examined according to the method of Imai et al. (8) . The erythrocyte 2,3-diphosphoglyceric acid (DPG) concentration was determined with a 2,3-DPG measurement kit (Sigma Chemical Co., St. Louis, MO). Fetal Hb (Hb F) was determined by alkali denaturation according to the method of Betke et al. (9) .
Globin was prepared by the method of Anson and Mirsky (10) and the chain was separated into individual components on a column of carboxymethyl-celhulose (CM-52, Whatman Laboratory Products, Inc.) with a developer of phosphate-buffered 8 M urea solution, pH = 6.7 (I1). Chemical modifications and enzymatic digestions of the aberrant chain for analysis of the primary structure followed, using the methods cited in the references, i.e., p-chloromercurybenzoic acid (PCMB) treatment (12) , aminoethylation (13) , performic acid oxidation (14) , cysteine cleavage (15, 16) , and digestions with trypsin (17) , chymotrypsin (18) , pepsin (19) , carboxypeptidase A (CP-A) (20) , and carboxypeptidase B (CP-B) (20) .
Fingerprinting of the peptides digested with these proteases was conducted on a silica gel plate (20 X 20 cm, Merck Chemical Div.,
Merck & Co., Inc., Rahway, NJ) with a combination of electrophoresis in one direction with pyridine, acetic acid, and water (1:10:500 in vol) and ascending thin layer chromatography in a rectangular with a developer of n-butanol, pyridine, acetic acid, and water (30:30:6:12 in vol). The peptide was acid-hydrolyzed under nitrogen, and amino acid residues were estimated with an automatic amino acid analyzer (Yanagimoto L-7; Yanagimoto Co., Ltd., Kyoto, Japan). DNA was prepared from leukocytes collected from 10 ml of peripheral blood (21) . To analyze a-and non a-globin genes, 4-tg aliquots of DNA were digested with the restriction enzymes SacI and BglII, respectively, under conditions recommended by the manufacturer (Takara Shuzo Co., Ltd., Kyoto, Japan). After digestion, the cleaved DNA was phenol-extracted, ethanol-precipitated, and redissolved in 30 gl of buffer solution, pH = 8.0. The DNA probes used in this experiment were derived from the recombinant plasmids of pJW 101, pJW 102, and pJW 151 (22) , each of which respectively contains a synthetic copy of the human a-, fl-, or y-globin gene in pMB 9 (23) .
The plasmids were cultured and isolated under containment conditions according to the guidelines of the Ministry of Education, Science, and Culture of Japan. The DNAs obtained were then electrophoresed on 0.6% agarose gel plates, transferred onto nitrocellulose filters (Toyo Roshi Co., Ltd., Tokyo, Japan), hybridized to a [a-32P]deoxycytidine triphosphate-labeled probe, and autoradiographed as previously described by Southern (24).
Results
The patient was a 41-yr-old Japanese male who was admitted to the Kobe Municipal Central Hospital, Kobe, Japan, for surgery for acute ulcerative colitis. Hematological examinations before surgery indicated an increased leukocyte count and slight anemia, but no tendency toward hemolytic anemia.
After the operation, the patient demonstrated marginal erythrocytosis, as shown in Table I . This condition has persisted for over 2 yr. Other aspects in his hematologic examinations have not been remarkable.
The patient has no siblings, and the causes of his parents' deaths are unknown.
Isoelectric focusing of fresh hemolysates from the propositus disclosed discrete bands of Hb Nb, Hb A, and Hb A2 from anode to cathode in the order described ( Fig. 1 ). An abnormal Hb A2 was not demonstrable. Separated hemoglobins were present in the following proportions: Hb Nb, 13.1%; Hb A, 83.3%; Hb A2, 2.6%; and Hb F, 0.95%.
Hb Nb focused at a similar position to Hb Ube-2 (a68 Asn -Asp) (25, 26) , which possesses one more negative charge than Hb A. However, when the separated Hb Nb was stored for -1 mo. at 4°C, it migrated more anodally than the freshly prepared Hb Nb, as if it had two more negative charges than Hb A ( the same mobility as that of Hb A. The site of focusing of the PMB-ab seemed to have two more negative charges than the PMB-aA, and no difference in the PMB-a~' in either the freshly prepared or the stored hemolysate was seen in their migration (Fig. 3) .
Instability tests of the abnormal Hb solution both by isopropanol and by heat were negative. Absorption spectra in a wavelength range of 250-650 nm in the oxy-, met-, and deoxy-forms of Hb Nb were the same as those of isomolar Hb A. This may indicate no heme depletion, normal oxygen binding capacity, or a normal tryptophan (a-14) notch, at 289 Fig. 6 ). The concentration of 2,3-DPG in erythrocytes was 11.7 ,umol/g Hb, which is within normal range (12.8±2.3).
Globin was prepared and an ar-chain was isolated from other globin chains chromatographically. Then tryptic digestion was carried out. The fingerprint map of the tryptic digest of the aNb-chain showed a missing a-T-14 spot. Other spots were located at their normal positions and showed the same amino acid residues as those from the aA-chain. This suggests that the a-T-14 peptide of the aNb-chain might be chemically joined with the tryptic core (am~-T-1 13 peptide) fraction. The tryptic core peptide was then treated with performic acid to convert cysteine and cystine residues to cysteic acid for chymotrypsin digestion. Fingerprinting of the digest, however, did not provide any abnormal peptides since all the spots on the map were normally positioned and had normal amino acid compositions. This suggests that there was no superimposition of the aNb-T-14 peptide on any of the spots observed on the map. To detect the aNb-T-14 peptide, which corresponds to the C-terminal peptide, the aNb-chain was individually treated with CP-B and CP-A. CP-B digestion of the a~'-chain demonstrated no release of amino acids from the C-terminus. This was in sharp contrast to the clear discovery of '1'Arg, 14OTyr, and '39Lys from the control aA-chain. CP-A did not release any amino acids from the C-terminus of the aNb-chain, nor, as expected (20), did it release any from the C-terminus of the ae-chain.
This evidence and the fact that the triplet codon CGU of Arg exists at the A141 of a-mRNA (27) led to the assumption that the amino acid at C-terminus of the aNb-chain was a cysteine with codon of UGU instead of the normally present Arg. This was proven by subjecting the aminoethylated a'-chain to CP-B digestion. The amino acids from the C-terminus of the aNbchain were detected as aminoethylated 141Cys (AECys), 4 'Tyr, and '39Lys, with amounts in the order described, and these were proportional to the incubation time course (Fig. 7) . Other evidence of this substitution was provided when the fingerprint of the pepsin digest of the performic acid-treated aNb-chain was compared with that of the normal control aA_ chain. One abnormal spot was clearly seen in isolation (Fig.  8) . Amino acid analysis ofthe acid hydrolysate of the abnormal spot showed that the residues arose from '37Thr-138Ser-'39Lys-4°Tyr-'4'CysS03H. Other indirect but supportive findings of this substitution were made when the aNb-chain was treated with 2-nitro-5-thiocyanobenzoic acid to cyanylate the thiol group of Cys and it was consequently cleaved at amino-sites of the peptide bond by Alkali (15, 16) , releasing the C-terminal thiocyanylated cysteine residue. Two segments from the aNb-chain were isolated by gel filtration in pure form and confirmed by amino acid analysis to be polypeptides composed of aNb'-103 and of aNb104-140 with missing cysteine residue at a 141 as expected. These findings may also support the possibility that the amino acid residue at aNb141 is a Cys, since the reaction removed specifically a Cys residue in the sequence of the peptide.
Based on the evidence above, it was concluded that an Arg at a 141 in Hb A was replaced by a Cys in this abnormal hemoglobin. Since this mutation has not been described previously, it was designated as Hb Nunobiki with a representation formula of a2141ArgBCys#2A-As for the propositus' a-globin gene organization, DNA fragments digested with the restriction enzyme SacI were hybridized to a radioactive probe, pJW 101. Three bands, estimated as 17, 13, and 4.2 kilobase pairs (Kb) in length, were clearly disclosed on an autoradiogram (Fig. 9) . Densitometric scanning indicated that the 4.2-Kb band occupied about twice as much space as that of the 17- 
SacI Discussion
Hb Nb is a fast-moving abnormal hemoglobin resulting from the replacement of a Cys for an Arg at a 141. The similar mobility of Hb Nunobiki to that of Hb Ube 2 (a68 AsnAsp) may correspond to one electron charge difference in the residue between Cys and Arg. It is obvious that the S atom of the thiol (-SH) in cysteine is susceptible to partial oxidation leading to sulfoxide (-SO-) or sulfinic acid (-SOO-) ion forms and that each of these forms possesses one more negative charge than neutral Cys. This might be why the Hb Nb in the stored hemolysate, which was devoid of reducing enzymes, migrated faster than that of the freshly prepared hemolysate. The negatively charged pigment with two additional charges found on isoelectric focusing of the PCMB-treated hemolysate is presumed to be an ab-chain composed of both partially oxidized Cys and PMB-modified Cys at a'l41, since both of these produce a two-electron charge difference from Arg in slightly alkaline medium. The mobility of PMB-al on isoelectric focusing also showed that the Cys at a'l41 did not take part in the formation of a disulfide bond. Moreover, no polymerization of Hb Nb was observed by gel filtration as was with the non-a hemoglobin variants of Hb Port Alegre (j#9 Ser -Cys) (30, 31) and Hb Ta-li (,83 Gly -Cys) (32), both of which allow polymerization of the molecule by disulfide bonding.
According to the hemoglobin molecule model of Perutz (33) , the Arg at a141 acts as one of the important amino acid residues responsible for constructing salt bridges with neighboring amino acids. These salt bridges favor stabilization of the T structure of the hemoglobin molecule. In its usual deoxy-hemoglobin form, the a-carboxyl group of the C-terminal Arg of the a-chain, a,, is linked to the a-amino group of the N-terminal Val of its partner a-chain, a2, and the guanidinium group of Arg at a, 141 is directed toward the a-carboxyl group of Asp at a2126 and to the a-amino group of Val at a21 via an intervening chloride ion (34, 35) . The formation of these ionic linkages might be interrupted in an a' subunit having C-terminal Cys instead of Arg. As a result, the stability of the T structure would be weakened, making the R structure favored over the T structure, as is characteristic of high oxygen affinity. The diminished 2,3-DPG effect of Hb Nb may be explained in the same manner. The predominance of the R structure in Hb Nb may secondarily affect a pair of # subunits, so that the 2,3-DPG molecule cannot be inserted properly into its binding site between two # subunits. Thus R to T conversion of Hb Nb would be hindered.
Five Hb variants with a substituted amino acid residue at the C-terminus of the a-chain have been reported; Hb Singapore (Arg -Pro) (36) , Hb Suresnes (Arg -His) (37), Hb J-Cubujugui (Arg -Ser) (38) , Hb Legnano (Arg -Leu) (39) , and Hb J-Camaguey (Arg -Gly) (40) . Examinations of oxygen affinity in Hb Singapore and Hb J-Camaguey have not been described, but the other variants are characterized by a high oxygen affinity that might be explained by a similar mechanism to that of the above-mentioned Hb Nb. The carriers of these variants, with the exception of Hb Singapore, have been reported to reveal slight polycythemia without any clinical symptoms. The carrier of Hb Nb has also exhibited marginal erythrocytosis. Hb Nb is thought to be a physiologically severe defect in oxygen transport, as indicated by its oxygen equilibrium curve. However, the proportion of Hb Nb to total hemoglobin is so small (13.1%) that the erythrocytosis is thought to be maintained in minimal.
It is also significant that Hb Nb exhibited a relatively slow rate of auto-oxidation. This finding might indicate that the replaced Cys at the ab-C-terminus consumes oxidants produced during incubation and protects the Hb Nb molecule from met-Hb formation. The high oxygen affinity of this variant may also contribute to stabilize the heme Fe(II) ion as observed in Hb Creteil ((#89 Ser -Asn) (41, 42 amino acids of aNb-T-14, "0Tyr, and 14'cysteic acid. However, detection of these amino acids on the map was unsuccessful. The substitution of Cys for Arg at a141 was, however, successfully verified by findings on CP-B digestion of the AE-aNbchain and on pepsin digestion of the performic acid treated aNb-chain, as already described.
The patient with Hb Nb had no hepatosplenomegaly nor any hemolytic tendencies. This might be because of the structural stability of the Hb Nb molecule. However, the production ratio of the aNb-chain to total a-chains in the propositus was small even when the sum of the proportions of Hb Nb (13.1%) and small amounts of abnormal Hb A2 and Hb F, which could not be determined, were added up. Therefore, the low production of the aNb-chain might be a reflection of a-globin gene expression. As an approach to clarifying this point, an analysis of the a-globin gene clusters of the propositus was performed, and revealed a normal duplicated a-globin gene in each haploid and the absence of more than four aglobin genes per diploid cell. More than the four a-globin genes are frequently seen in some racial groups (43) (44) (45) .
According to Leibhaber et al. (46) and Orkin et al. (47) , the two a-globin genes in a haploid called a 1-and a2-globin gene in order from 3' to 5' of the DNA sequence do not equally contribute to a-mRNA production. The transcription ratio of the a2/al-globin gene varies within a range of from 3/2 to 3/1. When this observation is considered regarding the patient of Hb Nb, and with the assumption that one of the two al-globin genes per diploid cell is converted to an aNb globin gene, an explanation for the low proportion of Hb Nb can be provided. A definitive explanation of the low aNbchain production requires further study.
